Literature DB >> 7252841

Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle.

M L Cohen, R W Fuller, K S Wiley.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 7252841

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  31 in total

1.  Central serotonin receptors: effector systems, physiological roles and regulation.

Authors:  P J Conn; E Sanders-Bush
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Characterization of an endothelial 5-hydroxytryptamine (5-HT) receptor mediating relaxation of the porcine coronary artery.

Authors:  G J Molderings; G Engel; E Roth; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

3.  Quipazine reduces food intake in the rat by activation of 5-HT2-receptors.

Authors:  G Hewson; G E Leighton; R G Hill; J Hughes
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

4.  Ergonovine-induced constrictions of epicardial coronary arteries in conscious dogs: alpha-adrenoceptors are not involved.

Authors:  J Holtz; W Held; O Sommer; G Kühne; E Bassenge
Journal:  Basic Res Cardiol       Date:  1982 May-Jun       Impact factor: 17.165

5.  The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.

Authors:  I Artaiz; G Romero; A Zazpe; A Monge; J M Calderó; J Roca; B Lasheras; J Del Río
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

6.  5-hydroxytryptamine releases adenosine 5'-triphosphate from nerve varicosities isolated from the myenteric plexus of guinea-pig ileum.

Authors:  M Al-Humayyd; T D White
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

7.  5-Carboxamide tryptamine, a compound with high affinity for 5-hydroxytryptamine1 binding sites, dilates arterioles and constricts arteriovenous anastomoses.

Authors:  P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

8.  Differential regulation of rat peripheral 5-HT(2A) and 5-HT(2B) receptor systems: influence of drug treatment.

Authors:  M J Enguix; L Sánchez; M Villazón; J Brea; H Tristán; H J Caruncho; M I Cadavid; M I Loza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-12       Impact factor: 3.000

9.  Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension.

Authors:  T Hedner; B Persson; G Berglund
Journal:  Br J Clin Pharmacol       Date:  1983-08       Impact factor: 4.335

10.  Actions of neuropeptide Y on innervated and denervated rat tail arteries.

Authors:  T O Neild
Journal:  J Physiol       Date:  1987-05       Impact factor: 5.182
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.